Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
Aldeyra Therapeutics (ALDX) PT Lowered to $12 at Canaccord Genuity
-
Aldeyra Therapeutics, Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Aldeyra Therapeutics (ALDX) Prices 2.2M Offering of Common Stock at $4.50/Share
-
Aldeyra Therapeutics, Inc. Prices Public Offering of Common Stock
-
Aldeyra Therapeutics (ALDX) Plans Offering of Common Stock
-
Aldeyra Therapeutics, Inc. Proposes Public Offering of Common Stock
-
Aldeyra Therapeutics to Present at the Canaccord Genuity Annual Growth Conference
-
Aldeyra Therapeutics to Present at the Canaccord Genuity 35th Annual Growth Conference
-
UPDATE: Canaccord Genuity Starts Aldeyra Therapeutics (ALDX) at Buy
-
Aldeyra Therapeutics Announces Closing of Common Stock Offering
-
Aldeyra Therapeutics Announces Pricing of Follow-On Public Offering of Common Stock
-
Aldeyra Therapeutics Launches Proposed Follow-on Public Offering of Common Stock
-
Aldeyra Therapeutics (ALDX) to Offer 3M Common Shares

